Market News

NASDAQ:ALGS News

2 stories
tradingview

ALGS Q2'26 Earnings: revenue estimate is 24.68M USD

ALGS (Aligos Therapeutics, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 24.68 million USD with EPS (earnings per share) anticipated at (1.09) USD. Learn more details a…

TradingView en
StocksUS
dow-jones

Aligos Therapeutics' Shares Rally Following $25M Payment From Xiamen Amoytop Biotech

By Grace YoonShares of Aligos Therapeutics surged after the company received a $25 million upfront payment as part of a licensing deal with Xiamen Amoytop Biotech.The stock was up 20% to $7.02 in after-hours trading Monday. Shares closed the market session up 4.7% at $5.85, but are still down 37% t…

Dow Jones Newswires en
StocksCNUS